BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 8466403)

  • 41. Proposed goals for analytical precision and accuracy in single-point diagnostic testing. Theoretical basis and comparison with data from College of American Pathologists proficiency surveys.
    Harris EK
    Arch Pathol Lab Med; 1988 Apr; 112(4):416-20. PubMed ID: 3355343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accuracy of participant results utilized as target values in the CAP Chemistry Survey Program.
    Hartmann AE; Naito HK; Burnett RW; Welch MJ
    Arch Pathol Lab Med; 1985 Oct; 109(10):894-903. PubMed ID: 3840001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors related to accuracy in office cholesterol testing. Iowa Academy of Family Physicians Research Network.
    Erickson R; Driscoll C; Dvorak L; Gjerde C; Glanzer J; Arteaga M; Pisney F; Williamson P
    J Fam Pract; 1991 Nov; 33(5):457-61. PubMed ID: 1940812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A manufacturer's approach to development of matrix robust methods.
    Rautela GS
    Arch Pathol Lab Med; 1993 Jul; 117(7):691-5. PubMed ID: 8323429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nordic surveys of analytical quality in clinical chemistry laboratories.
    Solberg HE; Björkhem I; Skrede S
    Scand J Clin Lab Invest Suppl; 1984; 172():103-13. PubMed ID: 6599511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A theoretical basis for clinically relevant proficiency testing evaluation limits. Sensitivity analysis of the effect of inherent test variability on acceptable method error.
    Ross JW
    Arch Pathol Lab Med; 1988 Apr; 112(4):421-34. PubMed ID: 3355344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of cholesterol bias due to a matrix effect of external quality assurance samples: how true is your cholesterol method?
    Pretorius CJ; Klingberg S; Johnson L; Park R; Wilgen U; Ungerer JP
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):538-41. PubMed ID: 23019601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analytic goals, concentration relationships, and the state of the art for clinical laboratory precision.
    Ross JW; Lawson NS
    Arch Pathol Lab Med; 1995 Jun; 119(6):495-513. PubMed ID: 7605165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The reference method value.
    Franzini C
    Ann Ist Super Sanita; 1991; 27(3):359-63. PubMed ID: 1809053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of 2 homogeneous high-density lipoprotein cholesterol assays.
    Hoang MP; Hirany SV; Parupia J; Devaraj S; Jialal I
    Arch Pathol Lab Med; 1998 Nov; 122(11):1005-9. PubMed ID: 9822130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A system to monitor a portion of the total testing process in medical clinics and laboratories: feasibility of a split-specimen design.
    Shahangian S; Krolak JM; Gaunt EE; Cohn RD
    Arch Pathol Lab Med; 1998 Jun; 122(6):503-11. PubMed ID: 9625417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interinstitutional comparison of bedside blood glucose monitoring program characteristics, accuracy performance, and quality control documentation: a College of American Pathologists Q-Probes study of bedside blood glucose monitoring performed in 226 small hospitals.
    Novis DA; Jones BA
    Arch Pathol Lab Med; 1998 Jun; 122(6):495-502. PubMed ID: 9625416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of analytical quality in Nordic clinical chemistry laboratories using data from contemporary national programs.
    Aronsson T; Bjørnstad P; Leskinen E; Uldall A; de Verdier CH
    Scand J Clin Lab Invest Suppl; 1984; 172():115-24. PubMed ID: 6599512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [How external quality evaluation programs affect the quality of laboratory results in routine practice in the Czech Republic].
    Valík D; Nekulová M; Pecen L; Votavová I
    Cas Lek Cesk; 2001 Aug; 140(17):538-44. PubMed ID: 11702480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generation and application of analytical goals in laboratory medicine.
    Fraser CG
    Ann Ist Super Sanita; 1991; 27(3):369-75. PubMed ID: 1809055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An evaluation of two compact analyzers used for lipid analysis.
    McKenney JM; Fary DF; Miller G; Proctor JD; Chinchili VM
    J Fam Pract; 1993 May; 36(5):526-33. PubMed ID: 8482937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Precision of a dry-chemistry method of lipid screening.
    Bowden RG; Kingery PM; Long L
    Public Health; 2006 Jun; 120(6):572-6. PubMed ID: 16730036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Analysis of the results of the SEIMC External Quality Control Program for HIV-1 and HCV viral loads, 2007].
    ; Orta Mira N; Guna Serrano Mdel R; Latorre Martínez JC; Ovies MR; Pérez JL; Gimeno Cardona C
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():8-13. PubMed ID: 19100161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A collaborative trial for the evaluation of blood cholesterol measurement in clinical laboratories in Italy.
    Malavasi B; Catapano A; Galli G; Franzini C
    Eur J Clin Chem Clin Biochem; 1992 Mar; 30(3):157-61. PubMed ID: 1599980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipid and lipoprotein testing in resource-limited laboratories.
    Myers GL
    Ethn Dis; 2003; 13(2 Suppl 2):S107-9. PubMed ID: 13677424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.